Chemotherapy-sparing treatment of haemophagocytic lymphohistiocytosis with intravenous immunoglobulins and corticosteroids

Haemophagocytic lymphohistiocytosis (HLH) can be a rapidly fatal disease. Current treatment in adults is extrapolated from the HLH-2004 protocol that specifies a regimen of etoposide, dexamethasone and cyclosporine. However, HLH presents as a spectrum of disease severity. A therapeutic challenge ari...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMJ Case Rep
Glavni autori: Chen, Evan C, Stefely, Jonathan A, Dey, Bimalangshu R, Dzik, Walter H
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2020
Teme:
Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation)
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7228143/
https://ncbi.nlm.nih.gov/pubmed/32376661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2020-234490
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items